16
Participants
Start Date
February 27, 2017
Primary Completion Date
May 12, 2017
Study Completion Date
May 12, 2017
Sotagliflozin (SAR439954)
"Pharmaceutical form: tablets~Route of administration: oral"
Rifampicin
"Pharmaceutical form: capsules~Route of administration: oral"
Investigational Site Number 250001, Gières
Lead Sponsor
Sanofi
INDUSTRY